Overview of NICE’s Elranatamab Managed Ac...

By João L. Carapinha

October 29, 2024

NICE recently recommended Elranatamab as an option for treating relapsed and refractory multiple myeloma in adults with a man...
Neoadjuvant Chemotherapy: Transforming Treatment for Advanced Ovarian Cancer
Impact of Health Insurance on Advanced Prostate Cancer Treatment Costs
Transforming Value-Based Oncology Care: A Multifaceted Approach
Bupa Launches Whole Genome Sequencing Pilot in UK
HARMONi-2 Trial Results Transforming NSCLC
KEYTRUDA Head Neck Cancer Phase 3 Trial
FDA Approves Inavolisib Breast Cancer Treatment
Soaring Drug Prices in Europe: A Strain on Health Systems and Industry
FDA’s Opdivo Lung Cancer Approval
Boosting HPV Cervical Cancer Awareness: Key Insights on Public Survey
Enhancing Health Outcomes with Geriatric-Specific Cancer Rehabilitation
New Innovations in Elderly Healthcare: Latest PBAC Outcomes